Your browser doesn't support javascript.
loading
The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Mougiakakos, Dimitrios; Bach, Christian; Böttcher, Martin; Beier, Fabian; Röhner, Linda; Stoll, Andrej; Rehli, Michael; Gebhard, Claudia; Lischer, Christopher; Eberhardt, Martin; Vera, Julio; Büttner-Herold, Maike; Bitterer, Katrin; Balzer, Heidi; Leffler, Magdalena; Jitschin, Simon; Hundemer, Michael; Awwad, Mohamed H S; Busch, Martin; Stenger, Steffen; Völkl, Simon; Schütz, Christian; Krönke, Jan; Mackensen, Andreas; Bruns, Heiko.
Afiliação
  • Mougiakakos D; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Bach C; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Böttcher M; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Beier F; Department of Oncology, Hematology and Stem Cell Transplantation, RWTH Medical School, Aachen, Germany.
  • Röhner L; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Stoll A; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Rehli M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Gebhard C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Lischer C; Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Eberhardt M; Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Vera J; Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Büttner-Herold M; Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Bitterer K; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Balzer H; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Leffler M; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Jitschin S; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Hundemer M; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Awwad MHS; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
  • Busch M; Institute for Medical Microbiology and Hygiene, University Hospital Ulm, Ulm, Germany.
  • Stenger S; Institute for Medical Microbiology and Hygiene, University Hospital Ulm, Ulm, Germany.
  • Völkl S; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Schütz C; Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
  • Krönke J; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Mackensen A; Charite Berlin Hematology Department at Campus Benjamin Franklin, Berlin, Germany.
  • Bruns H; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Cancer Immunol Res ; 9(3): 265-278, 2021 03.
Article em En | MEDLINE | ID: mdl-33563611

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Transcrição Ikaros / Microambiente Tumoral / Lenalidomida / Macrófagos Associados a Tumor / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Transcrição Ikaros / Microambiente Tumoral / Lenalidomida / Macrófagos Associados a Tumor / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article